Ionotropic and metabotropic glutamate receptor structure and pharmacology

James N. C. Kew; John A. Kemp

doi:10.1007/s00213-005-2200-z

journal article Feb 25, 2005

Ionotropic and metabotropic glutamate receptor structure and pharmacology

James N. C. Kew John A. Kemp

Psychopharmacology Vol. 179 No. 1 pp. 4-29 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/s00213-005-2200-z

Topics

No keywords indexed for this article. Browse by subject →

References

240

[1]

Ahmadian H, Nielsen B, Brauner-Osborne H, Johansen TN, Stensbol TB, Slok FA, Sekiyama N, Nakanishi S, Krogsgaard-Larsen P, Madsen U (1997) (S)-Homo-AMPA, a specific agonist at the mGlu6 subtype of metabotropic glutamic acid receptors. J Med Chem 40:3700?3705 10.1021/jm9703597

[2]

Alanine A, Bourson A, Buttelmann B, Gill R, Heitz MP, Mutel V, Pinard E, Trube G, Wyler R (2003) 1-Benzyloxy-4,5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorg Med Chem Lett 13:3155?3159 10.1016/s0960-894x(03)00713-3

[3]

Al-Hallaq RA, Jarabek BR, Fu Z, Vicini S, Wolfe BB, Yasuda RP (2002) Association of NR3A with the N-methyl-d-aspartate receptor NR1 and NR2 subunits. Mol Pharmacol 62:1119?1127 10.1124/mol.62.5.1119

[4]

Alt A, Weiss B, Ogden AM, Knauss JL, Oler J, Ho K, Large TH, Bleakman D (2004) Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitro. Neuropharmacology 46:793?806 10.1016/j.neuropharm.2003.11.026

[5]

Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 79:565?575 10.1111/j.1476-5381.1983.tb11031.x

[6]

Annoura H, Fukunaga A, Uesugi M, Tatsuoka T, Horikawa Y (1996) A novel class of antagonist for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropachromen-1a-carboxylates. Bioorg Med Chem Lett 6:763?766 10.1016/0960-894x(96)00104-7

[7]

Anson LC, Chen PE, Wyllie DA, Colquhoun D, Schoepfer R (1998) Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors. J Neurosci 18:581?589 10.1523/jneurosci.18-02-00581.1998

[8]

Anwyl R (1999) Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brains Res Rev 29:83?120 10.1016/s0165-0173(98)00050-2

[9]

Arai AC, Kessler M, Rogers G, Lynch G (2000) Effects of the potent Ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol Pharmacol 58:802?813 10.1124/mol.58.4.802

[10]

Arai AC, Xia Y-F, Rogers G, Lynch G, Kessler M (2002) Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action. J Pharmacol Exp Ther 303:1075?1085 10.1124/jpet.102.040360

[11]

Armstrong N, Gouaux E (2000) Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron 28:165?181 10.1016/s0896-6273(00)00094-5

[12]

Structure of a glutamate-receptor ligand-binding core in complex with kainate

Neali Armstrong, Yu Sun, Guo-Qiang Chen et al.

Nature 1998 10.1038/27692

[13]

Auberson YP, Allgeier H, Bischoff S, Lingenhoehl K, Moretti R, Schmutz M (2002) 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg Med Chem Lett 12:1099?1102 10.1016/s0960-894x(02)00074-4

[14]

Baron BM, Harrison BL, Kehne JH, Schmidt CJ, van Giersbergen PL, White HS, Siegel BW, Senyah Y, McCloskey TC, Fadayel GM, Taylor VL, Murawsky MK, Nyce P, Salituro FG (1997) Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. Eur J Pharmacol 323:181?192 10.1016/s0014-2999(97)00045-9

[15]

Barton ME, White HS (2004) The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression. Epilepsy Res 59:1?12 10.1016/j.eplepsyres.2003.12.010

[16]

Benveniste M, Mayer ML (1991) Kinetic analysis of antagonist action at N-methyl-d-aspartic acid receptors. Two binding sites each for glutamate and glycine. Biophys J 59:560?573 10.1016/s0006-3495(91)82272-x

[17]

Bhave G, Karim F, Carlton SM, Gereau RW (2001) Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci 4:417?423 10.1038/86075

[18]

Bhave G, Nadin BM, Brasier DJ, Glauner KS, Shah RD, Heinemann SF, Karim F, Gereau RW (2003) Membrane topology of a metabotropic glutamate receptor. J Biol Chem 278:30294?30301 10.1074/jbc.m303258200

[19]

Birch PJ, Grossman CJ, Hayes AG (1988) 6,7-Dinitro-quinoxaline-2,3-dion and 6-nitro,7-cyano-quinoxaline-2,3-dion antagonise responses to NMDA in the rat spinal cord via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol 156:177?180 10.1016/0014-2999(88)90163-x

[20]

Bleakman D, Ballyk BA, Schoepp DD, Palmer AJ, Bath CP, Sharpe EF, Wooley ML, Bufton HW, Kamboj RK, Tarnawa I, Lodge D (1996) Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology 35:1689?1702 10.1016/s0028-3908(96)00156-6

[21]

Bleakman D, Gates MR, Ogden AM, Mackowiak M (2002) Kainate receptor agonists, antagonists and allosteric modulators. Curr Pharm Des 8:873?885 10.2174/1381612024607108

[22]

Bormann J (1989) Memantine is a potent blocker of N-methyl-d-aspartate (NMDA) receptor channels. Eur J Pharmacol 166:591?592 10.1016/0014-2999(89)90385-3

[23]

Bortolotto ZA, Clarke VRJ, Delny CM, Parry MC, Smolders I, Vignes M, Ho KH, Miu P, Brinton BT, Fantaske R, Ogden A, Gates M, Ornstein PL, Lodge D, Bleakman D, Collingridge GL (1999) Kainate receptors are involved in synaptic plasticity. Nature 402:297?301 10.1038/46290

[24]

Bowie D, Mayer ML (1995) Inward rectification of both AMPA and kainate subtype glutamate receptors generated by polyamine-mediated ion channel block. Neuron 15:453?462 10.1016/0896-6273(95)90049-7

[25]

Brabet I, Parmentier M-L, De Colle C, Bockaert J, Acher F, Pin J-P (1998) Comparative effect of l-CCG-I, DCG-IV and ?-carboxy-l-glutamate on all cloned metabotropic glutamate receptor subtypes. Neuropharmacology 37:1043?1051 10.1016/s0028-3908(98)00091-4

[26]

Bräuner-Osborne H, Krogsgaard-Larsen P (1998) Pharmacology of (S)-homoquisqualic acid and (S)-2-amino-5-phosphopentanoic acid [(S)-AP5] at cloned metabotropic glutamate receptors. Br J Pharmacol 123:269?274 10.1038/sj.bjp.0701616

[27]

Bristow LJ, Hutson PH, Kulagowski JJ, Leeson PD, Matheson S, Murray F, Rathbone D, Saywell KL, Thorn L, Watt AP, Tricklebank MD (1996) Anticonvulsant and behavioral profile of l-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-d-aspartate receptor complex. J Pharmacol Exp Ther 279:492?501

[28]

Brown JC, Tse HW, Skifter DA, Christie JM, Andaloro VJ, Kemp MC, Watkins JC, Jane DE, Monaghan DT (1998) [3H]Homoquinolinate binds to a subpopulation of NMDA receptors and to a novel binding site. J Neurochem 71:1464?1470 10.1046/j.1471-4159.1998.71041464.x

[29]

Buttelmann B, Alanine A, Bourson A, Gill R, Heitz MP, Mutel V, Pinard E, Trube G, Wyler R (2003a) 2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorg Med Chem Lett 13:829?832 10.1016/s0960-894x(03)00007-6

[30]

Buttelmann B, Alanine A, Bourson A, Gill R, Heitz MP, Mutel V, Pinard E, Trube G, Wyler R (2003b) 4-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists. Bioorg Med Chem Lett 13:1759?1762 10.1016/s0960-894x(03)00232-4

[31]

Campbell UC, Lalwani K, Hernandez L, Kinney GG, Conn PJ, Bristow LJ (2004) The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. Psychopharmacology 175:310?318 10.1007/s00213-004-1827-5

[32]

Carroll FY, Stolle A, Beart PM, Voerste A, Brabet I, Mauler F, Joly C, Antonicek H, Bockaert J, Muller T, Pin J-P, Prezeau L (2001) BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol Pharmacol 59:965?973 10.1124/mol.59.5.965

[33]

Cartmell J, Schoepp DD (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75:889?907 10.1046/j.1471-4159.2000.0750889.x

[34]

Cartmell J, Monn JA, Schoepp DD (1999) The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviours in rats. J Pharmacol Exp Ther 291:161?170

[35]

Chaperon F, Muller W, Auberson YP, Tricklebank MD, Neijt HC (2003) Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-d-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit. Behav Pharmacol 14:477?487

[36]

Chappell AS, Sander JW, Brodie MJ, Chadwick D, Lledo A, Zhang D, Bjerke J, Kiesler GM, Arroyo S (2002) A crossover, add-on trial of talampanel in patients with refractory partial seizures. Neurology 58:1680?1682 10.1212/wnl.58.11.1680

[37]

Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, Shin Y, Cui J, Tu S, Sevarino KA, Nakanishi N, Tong G, Lipton SA, Zhang D (2002) Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415:793?798 10.1038/nature715

[38]

Chenard BL, Bordner J, Butler TW, Chambers LK, Collins MA, De Costa DL, Ducat MF, Dumont ML, Fox CB, Mena EE (1995) (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-d-aspartate responses. J Med Chem 38:3138?3145 10.1021/jm00016a017

[39]

Chenard BL, Menniti FS, Pagnozzi MJ, Shenk KD, Ewing FE, Welch WM (2000) Methaqualone derivatives are potent noncompetitive AMPA receptor antagonists. Bioorg Med Chem Lett 10:1203?1205 10.1016/s0960-894x(00)00216-x

[40]

Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, Corsi M, Orzi F, Conquet F (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4:873?874 10.1038/nn0901-873

[41]

Christensen JK, Varming T, Ahring PK, Jorgensen TD, Nielson EO (2004) In vitro characterization of 5-carboxyl-2,4-di-benzamido-benzoic acid (NS3763), a noncompetitive antagonist of GLUK5 receptors. J Pharmacol Exp Ther 309:1003?1010 10.1124/jpet.103.062794

[42]

Ciabarra AM, Sullivan JM, Gahn LG, Pecht G, Heinemann S, Sevarino KA (1995) Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 10:6498?6508 10.1523/jneurosci.15-10-06498.1995

[43]

Claiborne CF, McCauley JA, Libby BE, Curtis NR, Diggle HJ, Kulagowski JJ, Michelson SR, Anderson KD, Claremon DA, Freidinger RM, Bednar RA, Mosser SD, Gaul SL, Connolly TM, Condra CL, Bednar B, Stump GL, Lynch JJ, Macaulay A, Wafford KA, Koblan KS, Liverton NJ (2003) Orally efficacious NR2B-selective NMDA receptor antagonists. Bioorg Med Chem Lett 13:697?700 10.1016/s0960-894x(02)01061-2

[44]

Clark BP, Baker SR, Goldsworthy J, Harris JR, Kingston AE (1997) (+)-2-methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors. Bioorg Med Chem Lett 7:2777?2780 10.1016/s0960-894x(97)10071-3

[45]

Clarke VRJ, Ballyk BA, Hoo KH, Mandelzys A, Pellizzari A, Bath CP, Thomas J, Sharpe EF, Davies CH, Ornstein PL, Schoepp DD, Kamboj RK, Collingridge GL, Lodge D, Bleakman D (1997) A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389:599?603 10.1038/39315

[46]

Clements JD, Westbrook GL (1991) Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-d-aspartate receptor. Neuron 7:605?613 10.1016/0896-6273(91)90373-8

[47]

Contractor A, Gereau RW, Green T, Heinemann SF (1998) Direct effects of metabotropic glutamate receptor compounds on native and recombinant N-methyl-d-aspartate receptors. Proc Natl Acad Sci U S A 95:8969?8974 10.1073/pnas.95.15.8969

[48]

Contractor A, Swanson GT, Sailer A, O?Gorman S, Heinemann SF (2000) Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus. J Neurosci 20:8269?8278 10.1523/jneurosci.20-22-08269.2000

[49]

Contractor A, Sailer AW, Darstein M, Maron C, Xu J, Swanson GT, Heinemann SF (2003) Loss of kainate receptor-mediated heterosynaptic facilitation of mossy-fiber synapses in KA2?/? mice. J Neurosci 23:422?429 10.1523/jneurosci.23-02-00422.2003

[50]

Cosford NDP, Roppe J, Tehrani L, Schweiger EJ, Seiders TJ, Chaudary A, Rao S, Varney MA (2003a) [3H]-Methoxymethyl-MTEP and [3H]-Methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor. Bioorg Med Chem Lett 13:351?354 10.1016/s0960-894x(02)00997-6

Showing 50 of 240 references

Cited By

582

Structural Basis for ( S )-3,4-Dicarboxyphenylglycine (DCPG) As a Potent and Subtype Selective Agonist of the mGlu 8 Receptor

Qi Chen, Joseph D. Ho · 2018

Journal of Medicinal Chemistry

Conducting Nanomaterial Sensor Using Natural Receptors

Oh Seok Kwon, Hyun Seok Song · 2018

Chemical Reviews

A Guide to the Metabolic Pathways and Function of Metabolites Observed in Human Brain 1H Magnetic Resonance Spectra

Caroline D. Rae · 2013

Neurochemical Research

GluN2D Subunit-Containing NMDA Receptors Control Tissue Plasminogen Activator-Mediated Spatial Memory

Pauline Obiang, Richard Macrez · 2012

The Journal of Neuroscience

In Vivo Measurement of the Affinity and Density of Metabotropic Glutamate Receptor Subtype 1 in Rat Brain Using 18F-FITM in Small-Animal PET

Tomoteru Yamasaki, Masayui Fujinaga · 2012

Journal of Nuclear Medicine

Biostructural and Pharmacological Studies of Bicyclic Analogues of the 3-Isoxazolol Glutamate Receptor Agonist Ibotenic Acid

Karla Frydenvang, Darryl S. Pickering · 2010

Journal of Medicinal Chemistry

Expression and characterization of a brain-specific protein kinase BSK146 from zebrafish

Chih-Ming Chou, Yi-Chung Chen · 2006

Biochemical and Biophysical Researc...

Metrics

582

Citations

240

References

Details

Published: Feb 25, 2005
Vol/Issue: 179(1)
Pages: 4-29
License: View

Authors

Cite This Article

James N. C. Kew, John A. Kemp (2005). Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology, 179(1), 4-29. https://doi.org/10.1007/s00213-005-2200-z

Ionotropic and metabotropic glutamate receptor structure and pharmacology

You May Also Like